Novel lactone compounds from Mortierella verticillata that induce the human low density lipoprotein receptor gene: Fermentation, isolation, structural elucidation and biological activities

Journal of Antibiotics

Volumn 51, Issue 1, 1998, Pages 14-20

  Dekker, Koen A ^a   Aiello, Robert J ^a   Hirai, Hideo ^a   Inagaki, Taisuke ^a   Sakakibara, Tatsuo ^a   Suzuki, Yumiko ^a   Thompson, John F ^a   Yamauchi, Yuji ^a   Kojima, Nakao ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CJ 12950; CJ 13357; LACTONE; LOW DENSITY LIPOPROTEIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG ISOLATION; FERMENTATION; GENE INDUCTION; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIVER CELL; MORTIERELLA VERTICILLATA; NONHUMAN; PRIORITY JOURNAL; STIMULATION; ZYGOMYCETES;

EID: 0031888990     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.51.14     Document Type: Article

References (14)

1. GOLDSTEIN, J. L. & M. S. BROWN: Regulation of the mevalonate pathway. Nature 343: 425-430, 1990
2. O'DONNELL, K. L.: In Zygomycetes in culture, pp. 130-131, Univ. Georgia, Athens, GA, 1979
3. BAX, A.: Structure determination and spectral assignment by pulsed polarization transfer via long-range proton-carbon-13 couplings. J. Magn. Reson. 57: 314-318, 1984
4. MACKAY, D.; E. G. NEELAND & N. J. TAYLOR: Michael adducts of a half-blocked enedione as sources of 3-substituted 2,5-diketones and 2,5-dialkylfurans. J. Org. Chem. 51: 2351-2361, 1986
5. HIRSCH, J. A. & A. J. SZUR: The hydrolysis of α,α′-dimethoxydihydrofurans. J. Heterocycl. Chem. 9: 523-529, 1972
6. HELMS, G. L.; D. L. LINEMEYER, W. S. HORN, A. W. DOMBROWSKI, E. T. TURNER JONES, L. KOUPAL, K. F. BARTIZAL & W. ROZDILSKY (Merck & Co., Inc.): Cholesterol lowering agents and antifungal agents. EP 0505135A2, March 17, 1992
7. KAWASHIMA, A.; T. HAMAGUCHI, T. AKAMA & K. HANADA (Taisho Pharm. Co. Ltd.): Cholesterol lowering agent from Streptomyces griseoviridis. JP 04178379-A, June 25, 1992
8. OGASAWARA, M.; N. NARUSE, A. YOSHIMURA, Y. HAMAGISHI & T. OKI: Elevation of low density lipoprotein-receptor mRNA concentration in human hepatoma HepG2 cells by macrolide antibiotics. J. Antibiotics 46: 866-868, 1993
9. NIELD, H. & B. MIDDLETON: Valinomycin pretreatment induces LDL receptor activity in cultured human cells. Biochem. Soc. Trans. 21: 131, 1993
10. VOLPE, J. J. & K. A. OBERT: Cytoskeletal structures and 3-hydroxy-3-methylglutaryl coenzyme A reductase in C-6 glial cells. J. Biol. Chem. 256: 2016-2021, 1981
11. ELLSWORTH, J. L.; D. B. LLOYD, A. J. CARLSTROM & J. F. THOMPSON: Protein binding to the low density lipoprotein receptor promoter in vivo is differentially affected by gene activation in primary human cells. J. Lipid Res. 36: 383-392, 1995
12. LLOYD, D. B. & J. F. THOMPSON: Transcriptional modulators affect in vivo protein binding to the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase promoters. J. Biol. Chem. 270: 25812-25818, 1995
13. BIRCH, A. J.; O. C. MUSGRAVE, R. W. RICKARDS & H. SMITH: Studies in relation to biosynthesis. Part XX. The structure and biosynthesis of curvularin. J. Chem. Soc.: 3146-3152, 1959
14. ALDRIDGE, D. C.; S. GALT, D. GILES & W. B. TURNER: Metabolites of Lasiodiplodia theobromae. J. Chem. Soc.: 1623-1627, 1971